FdaApplication
ANDA 202040
Identifiers
- fda_app_no: ANDA202040
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2017-06-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELETRIPTAN HYDROBROMIDE | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET;ORAL |
| ELETRIPTAN HYDROBROMIDE | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET;ORAL |
2 products